> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# JPMorgan Reports 5.1% Passive Stake In Rhythm Pharmaceuticals, 3,563,667 Shares
- URL: https://www.bullished.co/jpmorgan-reports-5-1-passive-stake-in-rhythm-pharmaceuticals-3-563-667-shares-aeb06e0c/
- Published: 2026-10-13T18:10:56.000Z
- Updated: 2026-11-05T21:01:31.000Z
- Description: A Schedule 13G lists the holdings across six J.P. Morgan units, with the filer classed as a parent holding company.
- Author: Matteo Parrino
- Tags: SEC Filings, RYTM, Industry: Healthcare

JPMorgan Chase holds [3,563,667 shares](https://www.sec.gov/Archives/edgar/data/0000019617/000001961726000351/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) of [Rhythm Pharmaceuticals](https://www.bullished.co/tag/rytm/), or 5.1% of the class, according to a Schedule 13G filed Tuesday. The form is a passive ownership disclosure, and it lists September 30 as the date of the event.

## What the Schedule 13G says

[The 5.1%](https://www.sec.gov/Archives/edgar/data/0000019617/000001961726000351/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) is measured on the cover-page basis, which counts any warrants, options or convertibles the holder could exercise within 60 days in both the holding and the share base.

JPMorgan reports sole voting power over 3,358,216 shares and shared voting power over one share. It reports sole dispositive power, meaning the power to sell, over 3,560,983 shares. The filing classes JPMorgan Chase as a parent holding company.

The shares sit across six units named in the filing: J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities, JPMorgan Chase Bank, JPMorgan Asset Management (UK), J.P. Morgan Investment Management and J.P. Morgan Wealth Management Solutions.

## What it changes

Nothing about control. In the certification, JPMorgan says that, to the best of its knowledge and belief, the shares were acquired and are held in the ordinary course of business, not to change or influence control of Rhythm.

For holders, the filing adds a new reportable owner above the 5% line. Rhythm's market cap was $6.2 billion as of the original report on Tuesday at 2:07 p.m. ET.

The filing lists Rhythm's address as 222 Berkeley Street in Boston and JPMorgan's as 270 Park Avenue in New York.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — JPMORGAN CHASE & CO. re: RHYTHM PHARMACEUTICALS, INC. (RYTM)](https://www.sec.gov/Archives/edgar/data/0000019617/000001961726000351/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [Rhythm Pharmaceuticals (RYTM) Upgraded to Buy: Here's What You Should Know](https://finance.yahoo.com/markets/stocks/articles/rhythm-pharmaceuticals-rytm-upgraded-buy-150003284.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Progress In Prader-Willi And Genetically Defined Obesity Therapies](https://finance.yahoo.com/healthcare/articles/investors-may-respond-rhythm-pharmaceuticals-021635856.html?ref=bullished.co) — Yahoo Finance

### More on Rhythm Pharmaceuticals

- [Rhythm Owes LG Chem $350 Million Over Four Years, Backed By A $750 Million Loan Only $250 Million Funded](https://www.bullished.co/rhythm-owes-lg-chem-350-million-over-four-years-backed-by-a-750-million-loan-only-250-5697c2cd/)
- [Rhythm Stock Plunges 10%, Wiping Out $655 Million, As It Commits $350 Million To LG Chem](https://www.bullished.co/rhythm-stock-plunges-10-wiping-out-655-million-as-it-commits-350-million-to-lg-chem-f6033f9d/)
- [Rhythm Will Pay LG Chem $350 Million To Shrink Royalty On Its Obesity Drug Bivamelagon](https://www.bullished.co/rhythm-will-pay-lg-chem-350-million-to-shrink-royalty-on-its-obesity-drug-bivamelagon-dffcebcb/)

[All Rhythm Pharmaceuticals (RYTM) coverage →](https://www.bullished.co/tag/rytm/)